Your browser doesn't support javascript.
loading
Safety of synchronous prophylactic ablation of the anterior saphenous vein in patients undergoing great saphenous vein thermal ablation- 6 months follow-up data of the SYNCHRONOUS study.
Dietrich, Carmen K; Hirsch, Tobias; Hartmann, Karsten; Mattausch, Thomas; Wenzel, Hans-Christian; Zollmann, Philipp; Veltman, Jürgen; Weiler, Thomas K; Lengfellner, Guido; Müller, Lars; Stücker, Markus; Pannier, Felizitas; Uhlmann, Lorenz; Müller-Christmann, Christine.
Afiliación
  • Dietrich CK; Department for Dermatology, University of Heidelberg, Heidelberg, Germany.
  • Hirsch T; Praxis fuer Innere Medizin und Gefaßkrankheiten, Halle/Saale, Germany.
  • Hartmann K; Venenzentrum Freiburg, Freiburg, Germany.
  • Mattausch T; Venenzentrum am Bruhl, Leipzig, Germany.
  • Wenzel HC; Venenzentrum am Bruhl, Leipzig, Germany.
  • Zollmann P; MVZ Dr. Ph. Zollmann & Kollegen, Jena, Germany.
  • Veltman J; MVZ Dr. Ph. Zollmann & Kollegen, Jena, Germany.
  • Weiler TK; Venenzentrum Pforzheim, Pforzheim, Germany.
  • Lengfellner G; Venen-Fachpraxis Regensburg, Regensburg, Germany.
  • Müller L; Dermatologikum Hamburg, Hamburg, Germany.
  • Stücker M; Venenzentrum der Dermatologischen und Gefaßchirurgischen Kliniken, Bochum, Germany.
  • Pannier F; Private Practice Dermatology and Phlebology, Bonn, Germany.
  • Uhlmann L; Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
  • Müller-Christmann C; Department for Dermatology, University of Heidelberg, Heidelberg, Germany.
Phlebology ; : 2683555241257840, 2024 May 30.
Article en En | MEDLINE | ID: mdl-38815590
ABSTRACT

BACKGROUND:

The SYNCHRONOUS-study investigates simultaneous ASV-ablation with great saphenous vein (GSV) treatment in endovenous laser ablation (EVLA) for preventing varicose vein recurrence. This sub-study examines complication rates associated with prophylactic ASV-ablation.

METHODS:

Among 1173 patients with refluxing GSV, 604 underwent GSV-ablation only, and 569 received additional ASV-ablation. Complication rates were compared over 6 months.

RESULTS:

Approximately 80% of patients were complication-free with minor bruising and dysesthesia being most common complications. After 6 months, additional prophylactic ASV-ablation did not increase the rate of complications compared to GSV-only treatment.

CONCLUSION:

The 6-months follow-up data suggests that prophylactic ASV-closure, alongside GSV-treatment, is safe, with similar complication rates to GSV-only EVLA.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Phlebology Asunto de la revista: ANGIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Phlebology Asunto de la revista: ANGIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania